mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
-0.15 |
0.2 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.062 |
0.2 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.2 |